Revenue: The sum of all revenue fields included for a company's operating activities.
Generex Biotechnology Corp. (GNBTQ) had Revenue of $0.02M for the most recently reported fiscal quarter, ending 2021-04-30.
Income Statement Financials | |
Revenue |
$0.02M |
$9.22M |
|
$0.07M |
|
$-0.05M |
|
$6.38M |
|
$-6.36M |
|
$14.85M |
|
$8.49M |
|
$8.49M |
|
$8.49M |
|
$8.49M |
|
$8.49M |
|
$8.49M |
|
$-6.36M |
|
$-6.10M |
|
114.61M |
|
140.41M |
|
$0.08 |
|
$-0.04 |
|
Balance Sheet Financials | |
$2.47M |
|
$0.12M |
|
$43.45M |
|
$45.92M |
|
$64.07M |
|
$0.55M |
|
$25.93M |
|
$90.01M |
|
$-44.08M |
|
$-87.25M |
|
$-44.08M |
|
116.28M |
|
Cash Flow Statement Financials | |
$-1.74M |
|
-- |
|
$3.40M |
|
$0.02M |
|
$1.68M |
|
$1.66M |
|
$2.17M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
0.04 |
|
-- |
|
-- |
|
-0.01 |
|
-0.21 |
|
-218.89% |
|
-30748.75% |
|
-30748.75% |
|
-- |
|
41001.85% |
|
44564.14% |
|
$-1.74M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.28 |
|
0.40 |
|
227.46 |
|
-19.25% |
|
-9.73% |
|
18.48% |
|
-19.49% |
|
$-0.38 |
|
$-0.01 |
|
$-0.01 |